Perioperative outcomes of goal-directed versus conventional fluid therapy in radical cystectomy with enhanced recovery protocol.


Journal

International urology and nephrology
ISSN: 1573-2584
Titre abrégé: Int Urol Nephrol
Pays: Netherlands
ID NLM: 0262521

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 30 04 2021
accepted: 25 05 2021
pubmed: 6 6 2021
medline: 21 1 2022
entrez: 5 6 2021
Statut: ppublish

Résumé

The aim of this study is to evaluate the intra/perioperative fluid management and early postoperative outcomes of patients who underwent radical cystectomy with Enhanced Recovery After Surgery protocol, using goal-directed fluid therapy compared to conventional fluid therapy. This cohort study included patients who underwent open RC for urothelial bladder carcinoma with intent to cure and Enhanced Recovery After Surgery protocol between May 2012 and August 2019. Patients who had palliative or salvage cystectomy and/or adjunct procedures, as well as those with missing detailed perioperative data were excluded. Data were compared between patients who received goal-directed fluid therapy using stroke volume variation by FloTrac™/Vigileo system (n = 119) and conventional fluid therapy based on the anesthesiologist discretion (n = 192). Primary outcome variable was 90-day complications and secondary outcome measures included in-hospital GFR trend, length of stay, and 90-day readmission. The goal-directed fluid therapy group received less total and net intra/perioperative fluid, yet early postoperative glomerular filtration rate trends were similar between both groups (p = 0.7). Estimated blood loss, blood transfusion, index hospital stay, 90-day complication and readmission rates were also comparable between the two groups. Multivariable logistic regression showed no significant association between perioperative fluid management method and 90-day complication rate (OR 1.4, 95% CI 0.8-2.4, p = 0.2). Stroke volume variation guided goal-directed fluid therapy is safe in radical cystectomy without compromising the renal function. It is associated with less intra- and perioperative fluid infusion; however, no association with hospital stay, 90-day complication or readmission rates were noted.

Identifiants

pubmed: 34089170
doi: 10.1007/s11255-021-02903-w
pii: 10.1007/s11255-021-02903-w
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1827-1833

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Références

Siegel RL, Miller KD, Jemal A (2020) Cancer statistics. CA Cancer J Clin 70:7–30. https://doi.org/10.3322/caac.21590
doi: 10.3322/caac.21590 pubmed: 31912902
Shabsigh A, Korets R, Vora KC et al (2009) Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55:164–174. https://doi.org/10.1016/j.eururo.2008.07.031
doi: 10.1016/j.eururo.2008.07.031 pubmed: 18675501
Daneshmand S, Ahmadi H, Schuckman AK et al (2014) Enhanced recovery protocol after radical cystectomy for bladder cancer. J Urol 192:50–55. https://doi.org/10.1016/j.juro.2014.01.097
doi: 10.1016/j.juro.2014.01.097 pubmed: 24518775
Djaladat H, Katebian B, Bazargani ST et al (2017) 90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study. World J Urol 35:907–911. https://doi.org/10.1007/s00345-016-1950-z
doi: 10.1007/s00345-016-1950-z pubmed: 27734131
Tyson MD, Chang SS (2016) Enhanced recovery pathways versus standard care after cystectomy: a meta-analysis of the effect on perioperative outcomes. Eur Urol 70:995–1003. https://doi.org/10.1016/j.eururo.2016.05.031
doi: 10.1016/j.eururo.2016.05.031 pubmed: 27297680 pmcid: 5149115
Pozo C, Shariat SF, D’Andrea D et al (2019) Enhanced recovery after radical cystectomy. Curr Opin Urol 29:227–238. https://doi.org/10.1097/MOU.0000000000000594
doi: 10.1097/MOU.0000000000000594 pubmed: 30950886
Bundgaard-Nielsen M, Secher NH, Kehlet H (2009) “Liberal” vs. “restrictive” perioperative fluid therapy-a critical assessment of the evidence. Acta Anaesthesiol Scand 53:843–851. https://doi.org/10.1111/j.1399-6576.2009.02029.x
doi: 10.1111/j.1399-6576.2009.02029.x pubmed: 19519723
Corcoran T, Rhodes JE, Clarke S, Myles PS, Ho KM (2012) Perioperative fluid management strategies in major surgery: a stratified meta-analysis. Anesth Analg 114:640–651. https://doi.org/10.1213/ANE.0b013e318240d6eb
doi: 10.1213/ANE.0b013e318240d6eb pubmed: 22253274
Chappell D, Jacob M, Hofmann-Kiefer K et al (2008) A rational approach to perioperative fluid management. Anesthesiology 109:723–740. https://doi.org/10.1097/ALN.0b013e3181863117
doi: 10.1097/ALN.0b013e3181863117 pubmed: 18813052
Scheeren TW, Wiesenack C, Gerlach H et al (2013) Goal-directed intraoperative fluid therapy guided by stroke volume and its variation in high-risk surgical patients: a prospective randomized multicentre study. J Clin Monit Comput 27:225–233. https://doi.org/10.1007/s10877-013-9461-6
doi: 10.1007/s10877-013-9461-6 pubmed: 23558909
Ramsingh DS, Sanghvi C, Gamboa J et al (2013) Outcome impact of goal directed fluid therapy during high risk abdominal surgery in low to moderate risk patients: a randomized controlled trial. J Clin Monit Comput 27:249–257. https://doi.org/10.1007/s10877-012-9422-5
doi: 10.1007/s10877-012-9422-5 pubmed: 23264068
Bazargani ST, Ghodoussipour S, Tse B et al (2018) The association between intraoperative fluid intake and postoperative complications in patients undergoing radical cystectomy with an enhanced recovery protocol. World J Urol 36:401–407. https://doi.org/10.1007/s00345-017-2164-8
doi: 10.1007/s00345-017-2164-8 pubmed: 29299662
Skinner DG, Lieskovsky G (1998) Management of invasive high-grade bladder cancer. In: Skinner DG, Lieskovsky G (eds) Diagnosis and management of genitourinary cancer, vol 1. Saunders, Philadelphia, pp 295–312
Ghodoussipour S, Djaladat H (2018) An update in enhanced recovery following radical cystectomy. Curr Urol Rep 19:98. https://doi.org/10.1007/s11934-018-0855-3
doi: 10.1007/s11934-018-0855-3 pubmed: 30338450
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 1360123 pmcid: 1360123
Wuethrich PY, Burkhard FC, Thalmann GN et al (2014) Restrictive deferred hydration combined with preemptive norepinephrine infusion during radical cystectomy reduces postoperative complications and hospitalization time: a randomized clinical trial. Anesthesiology 20:365–377. https://doi.org/10.1097/ALN.0b013e3182a44440
doi: 10.1097/ALN.0b013e3182a44440
Furrer MA, Schneider MP, Löffel LM et al (2018) Impact of intra-operative fluid and noradrenaline administration on early postoperative renal function after cystectomy and urinary diversion: a retrospective observational cohort study. Eur J Anaesthesiol 35:641–640. https://doi.org/10.1097/EJA.0000000000000808
doi: 10.1097/EJA.0000000000000808 pubmed: 29652680
Kendrick JB, Kaye AD, Tong Y et al (2019) Goal-directed fluid therapy in the perioperative setting. J Anaesthesiol Clin Pharmacol 35:S29–S34. https://doi.org/10.4103/joacp.JOACP_26_18
doi: 10.4103/joacp.JOACP_26_18 pubmed: 31142956 pmcid: 6515723
Arslan-Carlon V, Tan KS, Dalbagni G et al (2020) Goal-directed versus standard fluid therapy to decrease ileus after open radical cystectomy: a prospective randomized controlled trial. Anesthesiology 133:293–303. https://doi.org/10.1097/ALN.0000000000003367
doi: 10.1097/ALN.0000000000003367 pubmed: 32472804
Kabon B, Sessler DI, Kurz A (2019) Crystalloid-colloid study team. Effect of intraoperative goal-directed balanced crystalloid versus colloid administration on major postoperative morbidity: a randomized trial. Anesthesiology 130:728–744. https://doi.org/10.1097/ALN.0000000000002601
doi: 10.1097/ALN.0000000000002601 pubmed: 30882476
Gómez-Izquierdo JC, Trainito A, Mirzakandov D et al (2017) Goal-directed fluid therapy does not reduce primary postoperative ileus after elective laparoscopic colorectal surgery: a randomized controlled trial. Anesthesiology 127:36–49. https://doi.org/10.1097/ALN.0000000000001663
doi: 10.1097/ALN.0000000000001663 pubmed: 28459732
Benes J, Giglio M, Brienza N et al (2014) The effects of goal-directed fluid therapy based on dynamic parameters on post-surgical outcome: a meta-analysis of randomized controlled trials. Crit Care 18:584. https://doi.org/10.1186/s13054-014-0584-z
doi: 10.1186/s13054-014-0584-z pubmed: 25348900 pmcid: 4234857
Deng QW, Tan WC, Zhao BC et al (2018) Is goal-directed fluid therapy based on dynamic variables alone sufficient to improve clinical outcomes among patients undergoing surgery? A meta-analysis. Crit Care 22:298. https://doi.org/10.1186/s13054-018-2251-2
doi: 10.1186/s13054-018-2251-2 pubmed: 30428928 pmcid: 6237035
Calvo-Vecino JM, Ripollés-Melchor J, Mythen MG et al (2018) Effect of goal-directed haemodynamic therapy on postoperative complications in low-moderate risk surgical patients: a multicentre randomised controlled trial (FEDORA trial). Br J Anaesth 120:734–744. https://doi.org/10.1016/j.bja.2017.12.018
doi: 10.1016/j.bja.2017.12.018 pubmed: 29576114
Pillai P, McEleavy I, Gaughan M et al (2011) A double-blind randomized controlled clinical trial to assess the effect of Doppler optimized intraoperative fluid management on outcome following radical cystectomy. J Urol 186:2201–2206. https://doi.org/10.1016/j.juro.2011.07.093
doi: 10.1016/j.juro.2011.07.093 pubmed: 22014804
Patel SY, Garcia Getting RE, Alford B et al (2018) Improved outcomes of Enhanced Recovery After Surgery (ERAS) protocol for radical cystectomy with addition of a multidisciplinary care process in a US comprehensive cancer care center. World J Surg 42:2701–2707. https://doi.org/10.1007/s00268-018-4665-z
doi: 10.1007/s00268-018-4665-z pubmed: 29750321 pmcid: 7771278
Myles PS, Bellomo R, Corcoran T et al (2018) Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med 378:2263–2274. https://doi.org/10.1056/NEJMoa1801601
doi: 10.1056/NEJMoa1801601 pubmed: 29742967
Hanna PT, Peterson M, Albersheim J et al (2020) Acute kidney injury following enhanced recovery after surgery in patients undergoing radical cystectomy. J Urol 204:982–988. https://doi.org/10.1097/JU.0000000000001153
doi: 10.1097/JU.0000000000001153 pubmed: 32469268
Kong YG, Kim JY, Yu J et al (2016) Efficacy and safety of stroke volume variation-guided fluid therapy for reducing blood loss and transfusion requirements during radical cystectomy: a randomized clinical trial. Medicine 95:e3685. https://doi.org/10.1097/MD.0000000000003685
doi: 10.1097/MD.0000000000003685 pubmed: 27175706 pmcid: 4902548

Auteurs

Alireza Ghoreifi (A)

Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, USC, 1441 Eastlake Ave. NOR 7416, Los Angeles, CA, 90089, USA.

Michael F Basin (MF)

Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, USC, 1441 Eastlake Ave. NOR 7416, Los Angeles, CA, 90089, USA.

Saum Ghodoussipour (S)

Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, USC, 1441 Eastlake Ave. NOR 7416, Los Angeles, CA, 90089, USA.

Soroush T Bazargani (ST)

Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, USC, 1441 Eastlake Ave. NOR 7416, Los Angeles, CA, 90089, USA.

Erfan Amini (E)

Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, USC, 1441 Eastlake Ave. NOR 7416, Los Angeles, CA, 90089, USA.

Mohammad Aslzare (M)

Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, USC, 1441 Eastlake Ave. NOR 7416, Los Angeles, CA, 90089, USA.

Jie Cai (J)

Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, USC, 1441 Eastlake Ave. NOR 7416, Los Angeles, CA, 90089, USA.

Gus Miranda (G)

Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, USC, 1441 Eastlake Ave. NOR 7416, Los Angeles, CA, 90089, USA.

Shihab Sugeir (S)

Department of Anesthesiology, University of Southern California, Los Angeles, CA, USA.

Sumeet Bhanvadia (S)

Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, USC, 1441 Eastlake Ave. NOR 7416, Los Angeles, CA, 90089, USA.

Anne K Schuckman (AK)

Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, USC, 1441 Eastlake Ave. NOR 7416, Los Angeles, CA, 90089, USA.

Siamak Daneshmand (S)

Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, USC, 1441 Eastlake Ave. NOR 7416, Los Angeles, CA, 90089, USA.

Philip Lumb (P)

Department of Anesthesiology, University of Southern California, Los Angeles, CA, USA.

Hooman Djaladat (H)

Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, USC, 1441 Eastlake Ave. NOR 7416, Los Angeles, CA, 90089, USA. djaladat@med.usc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH